Your browser doesn't support javascript.
loading
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Knappskog, Stian; Berge, Elisabet O; Chrisanthar, Ranjan; Geisler, Stephanie; Staalesen, Vidar; Leirvaag, Beryl; Yndestad, Synnøve; de Faveri, Elise; Karlsen, Bård O; Wedge, David C; Akslen, Lars A; Lilleng, Peer K; Løkkevik, Erik; Lundgren, Steinar; Østenstad, Bjørn; Risberg, Terje; Mjaaland, Ingvild; Aas, Turid; Lønning, Per E.
Afiliación
  • Knappskog S; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: stian.knappskog@k2.uib.no.
  • Berge EO; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Chrisanthar R; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Geisler S; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Staalesen V; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Leirvaag B; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Yndestad S; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • de Faveri E; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Karlsen BO; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Wedge DC; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
  • Akslen LA; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Lilleng PK; Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Norway.
  • Løkkevik E; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Lundgren S; Department of Oncology, St. Olavs University Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Østenstad B; Department of Oncology, Oslo University Hospital, Ullevaal, Oslo, Norway.
  • Risberg T; Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway.
  • Mjaaland I; Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
  • Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway.
  • Lønning PE; Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Mol Oncol ; 9(8): 1553-64, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26004085
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Daño del ADN / Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Proteína de Retinoblastoma / Resistencia a Antineoplásicos / Antibióticos Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Daño del ADN / Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Proteína de Retinoblastoma / Resistencia a Antineoplásicos / Antibióticos Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article